SA
SISCAPA Assay Technologies, Inc.
SEC filingBiotechnology · Washington, DC
Amount raised$2Msold at filing
Total offering$2M
Investors in the raise1count reported to the SEC
FiledAug 28, 2025first sale Apr 29, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Constance L. SeniffExecutive Officer, Director
Terry W. PearsonDirector
Norman Liegh AndersonExecutive Officer, Director
Gus W. SalemDirector
Executive officers, directors and promoters as listed on the Form D.